A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects with Prostate Cancer

Trial Identifier: 9785-CL-0018
Sponsor: Astellas Pharma Global Development, Inc.
Collaborator:
Pfizer Inc.
Start Date: January 2020
Primary Completion Date: December 2020
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Moldova (Republic of) Chisinau, Moldova (Republic of)